InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
TheSilverFox121 Free
11/06/20 4:12 PM
profile icon
TheSilverFox121 Free
08/28/20 1:22 PM
profile icon
lipster Free
08/05/20 2:48 PM
profile icon
lipster Free
08/05/20 12:44 PM
profile icon
Supersue Free
08/05/20 12:39 PM
profile icon
lipster Free
08/05/20 12:23 PM
profile icon
Supersue Free
07/21/20 11:20 AM
profile icon
BigRaj Free
02/24/20 9:45 AM
profile icon
Dollar Bill Free
02/24/20 8:55 AM
profile icon
BigRaj Free
02/23/20 7:05 AM
profile icon
bleu22 Free
02/11/20 6:34 AM
profile icon
JoeWo Free
02/11/20 6:33 AM
profile icon
makinezmoney Free
01/23/20 8:54 AM
profile icon
Lambsheadranch Free
01/15/20 8:13 PM
profile icon
Lambsheadranch Free
01/08/20 2:28 PM
profile icon
TheSilverFox121 Free
01/08/20 11:25 AM
profile icon
Dollar Bill Free
01/08/20 11:24 AM
profile icon
TheSilverFox121 Free
01/08/20 10:40 AM
profile icon
bleu22 Free
01/08/20 9:39 AM
profile icon
TheSilverFox121 Free
01/07/20 2:31 PM
profile icon
LongTermHoldah Free
01/06/20 6:03 PM
profile icon
LongTermHoldah Free
01/06/20 1:51 PM
profile icon
deadjim Free
12/21/19 3:21 PM
profile icon
TheSilverFox121 Free
12/09/19 2:59 PM
profile icon
Lambsheadranch Free
12/09/19 1:09 PM
profile icon
bleu22 Free
12/06/19 4:56 PM
profile icon
sublime740 Free
12/06/19 9:17 AM
profile icon
sublime740 Free
12/04/19 2:32 PM
profile icon
givemetheloot Free
12/04/19 7:46 AM
profile icon
makinezmoney Free
12/03/19 3:49 PM

Onconova Therapeutics Inc Warrants (ONTXW) RSS Feed

Followers
7
Posters
13
Posts (Today)
0
Posts (Total)
35
Created
08/18/16
Type
Free
Moderators
Onconova Therapeutics, Inc., sometimes referred to as "we" or the "Company," is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using our proprietary chemistry platform, we have created an extensive library of targeted anti-cancer agents designed to work against cellular pathways important to cancer cells. We believe that the drug candidates in our pipeline have the potential to be efficacious in a variety of cancers. We have one actively enrolling Phase 3 clinical-stage product candidate and two other clinical-stage product candidates (one of which is being developed for treatment of acute radiation syndromes) and several preclinical programs. Substantially all of our current effort is focused on our lead product candidate, rigosertib. Read more: http://www.nasdaq.com/symbol/ontxw#ixzz4HjsdlYcz http://www.nasdaq.com/symbol/ontxw
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
ONTXW Latest News
  • No Recent News Available for this company!
New Post